data

R&D

Ensuring R&D investments deliver maximum potential: Notable ...

As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.

R&D

Data-driven disease research harnessing the genome

Ben Hargreaves speaks to the UK Biobank to learn more about their work building a dataset of 500,000 individuals.

R&D

Bioanalytical labs need to reimagine data to streamline thei...

The fundamental questions in the trial phases of drug development are “Does it work?”, “Is it safe?”, and “What else do we need to know?”

Digital

To fight rare diseases, win the data battle first

Innovation is the key to evolution. In the pharmaceutical space, brilliant advancements have occurred with drugs with large population pools.

Sales & Marketing

Veeva Commercial Summit '23: The power of connectivity

Veeva Systems’ Commercial Summit returned to Madrid for 2023, with over 1,500 life sciences industry professionals in attendance.

Digital

Retaining the human element of AI within pharma and healthca...

Artificial intelligence (AI) has been the word of 2023, but aside from the promises, what are the realities of its practical implementation in the life sciences setting?